T 0059/16 (Clostridial toxin/ ALLERGAN) of 11.09.2018
- European Case Law Identifier
- ECLI:EP:BA:2018:T005916.20180911
- Date of decision
- 11 September 2018
- Case number
- T 0059/16
- Petition for review of
- -
- Application number
- 06816283.3
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- NON-PROTEIN STABILIZED CLOSTRIDIAL TOXIN PHARMACEUTICAL COMPOSITIONS
- Applicant name
- ALLERGAN, INC.
- Opponent name
- IPSEN PHARMA S.A.S.
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(b)European Patent Convention Art 100(c)European Patent Convention Art 111(1)European Patent Convention Art 123(2)Rules of procedure of the Boards of Appeal Art 13(1)Rules of procedure of the Boards of Appeal Art 13(3)
- Keywords
- Grounds for opposition - added subject-matter (yes)
Late-filed auxiliary request - admitted (yes)
Auxiliary request - added subject-matter (no)
Claims - clarity in opposition proceedings
Sufficiency of disclosure - (yes)
Appeal decision - remittal to the department of first instance (yes) - Catchword
- -
- Cited cases
- G 0003/14
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division for further prosecution.